Knee osteoarthritis pain relief – and massive weight loss – from new GLP-1
· newatlas.com · popularity 21/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at newatlas.com →
Summary
Two Phase 3 clinical trials that involved more than 1,000 adults have significantly strengthened the case for Eli Lilly's experimental GLP-1-based drug retatrutide to gain FDA approval for both weight loss and relief from knee osteoarthritis (OA). Continue Reading Category: Obesity , Illnesses and conditions , Body and Mind Tags: GLP-1 receptor agonists , Weight Loss , clinical trials , Experimental , Drug development , Arthritis , Healthy aging , Obesity , Eli Lilly
Found in: New Atlas. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.